Is eltrombopag a medically insured drug?
Eltrombopag (Eltrombopag) has been included in the anti-bleeding category B of China’s medical insurance, so it can be considered a medical insurance drug.
According to the National Medical Security Administration and relevant policy documents, eltrombopag has been included in the anti-bleeding category B in China’s medical insurance catalog. This means that eligible patients can receive Medicare reimbursement when purchasing eltrombopag.
Eltrombopag's medical insurance reimbursement is usually limited to patients with specific indications, such as patients with idiopathic thrombocytopenia who have previously failed to respond to glucocorticoids and immunoglobulins. Therefore, not all patients who need eltrombopag treatment can enjoy medical insurance reimbursement, and the details need to be determined based on the doctor's diagnosis and medical insurance policy.
The specific proportion of medical insurance reimbursement varies depending on regions and medical insurance policies. Generally speaking, eltrombopag is a Class B medical insurance drug, and patients can enjoy partial reimbursement. However, the specific self-pay ratio may be as low as 20% or higher, depending on local medical insurance policies and reimbursement ratios. Patients can make reimbursement directly at the hospital. When purchasing eltrombopag, relevant diagnosis certificates and treatment records must be provided to the hospital to prove that the patient meets the reimbursement conditions. The hospital will conduct reimbursement operations based on the patient's specific situation and local medical insurance policies.
Since Eltrombopag has been included in the scope of medical insurance, eligible patients can enjoy partial reimbursement when purchasing. However, the specific out-of-pocket amount varies depending on factors such as region, medical insurance policy, and drug prices. Typically, the out-of-pocket rate may be as low as 20% or higher, depending on local health insurance policies and reimbursement rates.
Since the specific ratio and process of medical insurance reimbursement may vary by region and medical insurance policy, it is recommended that patients learn more about local medical insurance policies before purchasing. Patients should strictly follow the doctor's instructions when using eltrombopag to ensure compliance. At the same time, attention should be paid to the storage conditions and validity period of the medicine.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)